These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8180425

  • 1. Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha.
    Ambrosetti A, Krampera M, Veneri D, Meneghini V, Aprili F, Martinelli G, Pizzolo G, Perona G.
    Int J Clin Lab Res; 1994; 24(1):58-9. PubMed ID: 8180425
    [Abstract] [Full Text] [Related]

  • 2. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
    Martinelli G, Testoni N, Zuffa E, Visani G, Zinzani PL, Zaccaria A, Farabegoli P, Arpinati M, Amabile M, Tura S.
    Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM, Talpaz M.
    Leuk Lymphoma; 1993 Jun; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract] [Full Text] [Related]

  • 4. Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
    Kawakubo K, Ohyashiki JH, Ohyashiki K, Tauchi T, Ohto T, Toyama K.
    Cancer Genet Cytogenet; 1992 Feb; 58(2):165-8. PubMed ID: 1551082
    [Abstract] [Full Text] [Related]

  • 5. Extramedullary blast crisis in chronic myeloid leukemia.
    Specchia G, Palumbo G, Pastore D, Mininni D, Mestice A, Liso V.
    Leuk Res; 1996 Feb; 20(11-12):905-8. PubMed ID: 9009247
    [Abstract] [Full Text] [Related]

  • 6. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Meloni G, Capria S, Vignetti M, Mandelli F, Modena V.
    Blood; 1997 Jun 15; 89(12):4659. PubMed ID: 9192793
    [No Abstract] [Full Text] [Related]

  • 7. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H, Utsugisawa T, Murai K, Narigasawa Y, Miyairi Y, Shimosegawa K, Suzuki T, Kuriya S.
    Int J Hematol; 1995 Jun 15; 61(4):229-30. PubMed ID: 8547613
    [No Abstract] [Full Text] [Related]

  • 8. Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.
    Fabbiano F, Santoro A, Di Trapani F, Marino MA, Pampinella M, Caronia F.
    Eur J Haematol; 1993 Aug 15; 51(2):122-3. PubMed ID: 8370420
    [No Abstract] [Full Text] [Related]

  • 9. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11).
    Li L, Ritterbach J, Harbott J, Schroyens W, Lohmeyer J, Pralle H, Lampert F.
    Cancer Genet Cytogenet; 1993 Jul 15; 68(2):131-4. PubMed ID: 8353804
    [Abstract] [Full Text] [Related]

  • 10. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.
    Meloni G, Foà R, Tosti S, Vignetti M, Gavosto F, Mandelli F.
    Haematologica; 1990 Jul 15; 75(6):502-5. PubMed ID: 2098290
    [Abstract] [Full Text] [Related]

  • 11. Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M, Keating MJ, Estey EH, O'Brien S, Beran M, McCredie KB, Gutterman J, Freireich EJ.
    Cancer; 1991 Sep 15; 68(6):1201-7. PubMed ID: 1873771
    [Abstract] [Full Text] [Related]

  • 12. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V, Aurer I, Hitrec V, Boban D, Nemet D, Zupancić-Salek S, Labar B.
    Haematologica; 1995 Sep 15; 80(4):338-40. PubMed ID: 7590504
    [Abstract] [Full Text] [Related]

  • 13. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U, Aleskog A, Björnberg A, Höglund M, Simonsson B, Bengtsson M, Barbany G, Larsson R, Lindhagen E.
    Anticancer Drugs; 2006 Jul 15; 17(6):631-9. PubMed ID: 16917208
    [Abstract] [Full Text] [Related]

  • 14. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia.
    Cağirgan S, Sencan M, Tombuloglu M, Ozdemir E, Hekimgil M, Büyükkeçeci F.
    Leuk Lymphoma; 1998 Apr 15; 29(3-4):423-5. PubMed ID: 9684940
    [Abstract] [Full Text] [Related]

  • 15. Very long survival in complete cytogenetic remission in an adolescent with lymphoid blast crisis of chronic myeloid leukemia after treatment with intensive ALL-directed chemotherapy combined with continuous imatinib.
    Maschan A, Novichkova G, Miakova N, Persiantseva M.
    Pediatr Blood Cancer; 2016 Dec 15; 63(12):2243-2245. PubMed ID: 27434016
    [Abstract] [Full Text] [Related]

  • 16. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD.
    Eur J Haematol; 2003 Apr 15; 70(4):235-9. PubMed ID: 12656747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Interferon therapy for chronic myelogenous leukemia].
    Shibata A, Hashimoto S.
    Gan To Kagaku Ryoho; 1993 Feb 15; 20(2):200-6. PubMed ID: 8434957
    [Abstract] [Full Text] [Related]

  • 19. A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.
    Haematologica; 1992 Feb 15; 77(3):204-14. PubMed ID: 1427426
    [Abstract] [Full Text] [Related]

  • 20. Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate.
    Kanda Y, Chiba S, Honda H, Hirai H, Yazaki Y.
    Leuk Lymphoma; 1999 Mar 15; 33(1-2):193-7. PubMed ID: 10194138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.